alexa Formulation Of A Chewing Gum For Treating Oral Candidiasis
ISSN: 2332-0702

Journal of Oral Hygiene & Health
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

2nd International Conference on Restorative Dentistry and Prosthodontics
May 01-02, 2017 Toronto, Canada

Jones Ozokwere, Eugene Olivier, Mulamba Gedeon and Patrick Demana
Tshwane University of Technology, South Africa
University of Limpopo, South Africa
ScientificTracks Abstracts: J Oral Hyg Health
DOI: 10.4172/2332-0702-C1-005
Abstract
Fungal infections have become major causes of morbidity and mortality among immuno-compromised patients. Oral candidiasis is a fungal infection caused the opportunistic pathogen named Candida albicans. Conventional available treatments for oral candidiasis include topical antifungal azoles such as Miconazole, Amphotericin B and Nystatin. Miconazole, in various formulations (gels, lozenges or mixtures) for local application, is an effective antimycotic drug for treating oral candidiasis. However the increase of resistant micro-organisms to conventional treatment is becoming a challenge, researchers are trying to identify potential drugs and alternatives treatments with better and improved therapeutic effects and fewer adverse effects. Essential oils have been used for the treatment of several diseases. They possess antibacterial, antifungal, antiviral and antiseptic activities. Certain essential oils have been shown to have antifungal activity or reduce the risk of fungal infections. In this study, a selection of essential oils was made and evaluated based on their anti-candidal activity, organoleptic properties, availability and minimum inhibitory concentration for possible inclusion and formulation into the chewing gum as an active pharmaceutical ingredient. Preformulation studies were conducted to identify suitable excipients and evaluate physicochemical compatibilities of the actives with selected excipients. From three placebo formulations obtained from the gum base manufacturer, preliminary development of the formulation was done. A series of formulations were developed by varying different tablet components. The active pharmaceutical ingredients (API’s) were included in the gum core both at 2% (w/w) of the MCG composition. The formula was subjected to scale-up. Produced MCG’s from the scale-up were film coated to improve stability. Finished products were subjected to post-compression evaluation including in vitro release of the API’s from the dosage form. This study proved that it is possible to develop a medicated chewing gum with a combination of essential oils as active substances for the effective treatment of oral candidiasis.
Biography

Email: jocs_scoj@yahoo.com

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsonline.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsonline.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsonline.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsonline.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsonline.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsonline.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsonline.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsonline.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsonline.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsonline.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords